N, M., N, B., C, Y., N, L., DJ, W., SK, R., . . . HK, C. (2026). Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies. Diabetes care, 49(3), 460. https://doi.org/10.2337/dc25-1713
Chicago Style (17th ed.) CitationN, McCormick, et al. "Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies." Diabetes Care 49, no. 3 (2026): 460. https://doi.org/10.2337/dc25-1713.
MLA (9th ed.) CitationN, McCormick, et al. "Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies." Diabetes Care, vol. 49, no. 3, 2026, p. 460, https://doi.org/10.2337/dc25-1713.